New impella cardiac power device used in patient with cardiogenic shock due to nonischemic cardiomyopathy

Keyphrases

• Cardiogenic Shock 100%
• Impella 100%
• Nonischemic Cardiomyopathy 100%
• Cardiac Power 100%
• Power Device 100%
• Impella 2.5 50%
• Left Ventricular Ejection Fraction 33%
• Critically Ill Patients 16%
• Cardiac Function 16%
• Pulmonary Capillary Wedge Pressure 16%
• Cardiac Output 16%
• Medical History 16%
• Levels of Support 16%
• Liver Function 16%
• Multiple Organ Failure 16%
• Critically Ill 16%
• Shortness of Breath 16%
• Cardiac Index 16%
• No Complication 16%
• Young Males 16%
• Male Patients 16%
• Right Heart Catheterization 16%
• Monomorphic Ventricular Tachycardia 16%
• Prolonged Use 16%
• Right Atrial Pressure 16%
• Normal Sinus Rhythm 16%
• Hemodynamic Function 16%
• Mechanical Support 16%
• Non-obstructive Coronary Artery Disease 16%
• Left Heart Catheterization 16%
• Biventricular Failure 16%

Medicine and Dentistry

• Cardiogenic Shock 100%
• Heart Left Ventricle Ejection Fraction 100%
• Nonischemic Cardiomyopathy 100%
• Coronary Artery Disease 50%
• Multiple Organ Dysfunction Syndrome 50%
• Heart Function 50%
• Pulmonary Artery Occlusion Pressure 50%
• Heart Output 50%
• Medical History 50%
• Hemodynamic 50%
• Dyspnea 50%
• Cardiac Catheterization 50%
• Monomorphic Ventricular Tachycardia 50%
• Liver Function 50%
• Sinus Rhythm 50%
• Heart Right Atrium Pressure 50%